Mc. Martinez et al., RESPONSES TO VASOPRESSIN AND DESMOPRESSIN OF HUMAN CEREBRAL-ARTERIES, The Journal of pharmacology and experimental therapeutics, 270(2), 1994, pp. 622-627
The effects of vasopressin and deamino-8-D-arginine vasopressin (desmo
pressin) were studied in isolated rings from branches (0.8-1.2 mm in e
xternal diameter) of human middle cerebral arteries obtained during au
topsy of 27 patients who had died 3 to 10 hr before. In arterial rings
under resting tension, vasopressin produced concentration-dependent c
ontractions with an EC(50) of 7.2 x 10(-10) M. The vasopressin V-1 rec
eptor antagonist ta-mercapto-beta,beta-cyclopentamethylenepropionic ci
d)-2-(O-methyl)-tyrosine-8-arginine)vasopressin] (10(-6) M) displaced
the control curve to vasopressin 1250-fold to the right in a parallel
manner. The mixed V-1-V-2 receptor antagonist ta-mercapto-beta,beta-cy
clopentamethylenepropionic sine-4-valine-8-arginine-9-desglycine)vasop
ressin] (10(-8) M) depressed both the slope and maximal response of th
e control curve for vasopressin. Vasopressin produced further contract
ions in arterial rings with or without endothelium precontracted with
prostaglandin F-2 alpha or norepinephrine. In precontracted arterial r
ings and previously treated with the V-1 vasopressinergic antagonist t
a-mercapto-beta,beta-cyclopentamethylenepropionic cid)-2-(O-methyl)-ty
rosine-8-arginine)vasopressin] (10(-6) M) vasopressin caused endotheli
um-indpendent relaxation. The relaxation to vasopressin was reduced si
gnificantly by indomethacin (10(-6) M) and unaffected by the V-1-V-2 r
eceptor antagonist [(1-(beta-mercapto-beta, beta-cyclopentamethylenepr
opionic sine-4-valine-8-arginine-9-desglycine)vasopressin] (10(-6) M)
or by N-G-monomethyl-L-arginine (10(-4) M). The selective V-2 receptor
agonist deamino-8-D-arginine vasopressin caused concentration-depende
nt relaxations in precontracted arterial rings that were inhibited by
the mixed V-1-V-2 receptor antagonist but not by the V-1 receptor anta
gonist or by pretreatment with N-G-monomethyl-L-arginine. These observ
ations indicate that vasopressin is primarily a constrictor of human c
erebral arteries by V-1 receptor stimulation. Vasopressin causes dilat
ation of human cerebral arteries only if V-1 receptor blockade is pres
ent. This relaxation appears to be mediated by the release of vasodila
tor prostaglandins and is independent of V-2 receptor stimulation or r
elease of nitric oxide. In contrast, deamino-8-D-arginine vasopressin
elicits relaxation that is largely dependent on V-2 receptor stimulati
on.